KYMR
vs
U
USBC
KYMR
Over the past 12 months, KYMR has underperformed USBC, delivering a return of +100% compared to the USBC's +479 900% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
KYMR
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
77.13
USD
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.48
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
KYMR, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Kymera Therapeutics Inc
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
KYMR, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Kymera Therapeutics Inc | ||||
|
U
|
US BioTec Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
KYMR, USBC
Performance By Year
KYMR, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
